Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celldex Therapeutics (CLDX) Prepaid Assets (2016 - 2025)

Celldex Therapeutics (CLDX) has 16 years of Prepaid Assets data on record, last reported at $14.1 million in Q4 2025.

  • For Q4 2025, Prepaid Assets fell 33.53% year-over-year to $14.1 million; the TTM value through Dec 2025 reached $14.1 million, down 33.53%, while the annual FY2025 figure was $14.1 million, 33.53% down from the prior year.
  • Prepaid Assets reached $14.1 million in Q4 2025 per CLDX's latest filing, down from $21.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $22.0 million in Q3 2024 and bottomed at $2.4 million in Q4 2021.
  • Average Prepaid Assets over 5 years is $11.4 million, with a median of $10.6 million recorded in 2022.
  • Peak YoY movement for Prepaid Assets: surged 412.78% in 2022, then tumbled 55.89% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $2.4 million in 2021, then soared by 412.78% to $12.4 million in 2022, then crashed by 55.89% to $5.5 million in 2023, then surged by 287.38% to $21.2 million in 2024, then plummeted by 33.53% to $14.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $14.1 million in Q4 2025, $21.0 million in Q3 2025, and $18.0 million in Q2 2025.